Anti-Cancer Drug Design

ISSN 0266-9536, Online ISSN: 1460-2148
Ceased publication in 2001

Publisher: Cognizant Communication Corporation

Related content

By this: publisher
In this subject: Pharmacology

Volume 14, Number 6, 1999

Purchase this issue

Virus-detected enzyme prodrug therapy using CB1954
pp. 461-472(12)
Authors: Grove J.; Searle P.; Weedon S.; Green N.; McNeish I.; Kerr D.

Antitumour prodrug development using cytochrome P450 (CYP) mediated activation
pp. 473-486(14)
Authors: Patterson L.; McKeown S.; Robson T.; Gallagher R.; Raleigh S.; Orr S.

Nitracrine N-oxides: effects of variations in the nature of the side chain N-oxide on hypoxia-selective cytotoxicity
pp. 487-497(11)
Authors: Lee H.; Wilson W.; Denny W.

Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs
pp. 499-506(8)
Authors: Conover C.; Greenwald R.; Pendri A.; Shum K.

Intensely cytotoxic anthracycline prodrugs: galactosides
pp. 507-515(9)
Authors: Bakina E.; Farquhar D.

Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT)
pp. 517-538(22)
Authors: Niculescu-Duvaz I.; Friedlos F.; Niculescu-Duvaz D.; Davies L.; Springer C.

Synthesis and antitumor activities of amino acid prodrugs of amino-combretastatins
pp. 539-548(10)
Authors: Ohsumi K.; Hatanaka T.; Nakagawa R.; Fukuda Y.; Morinaga Y.; Suga Y.; Nihei Y.; Ohishi K.; Akiyama Y.; Tsuji T.

The complete issue is available for purchase

$125.00

Purchasing this issue will give you access to all of the articles listed above for 2 days. You may also purchase articles individually by visiting the abstract page of the article. The exact price (including tax) will be displayed in your shopping cart before you check out. You will be able to remove this item from your shopping cart at any time before you have completed check-out.

Add to cart